Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > REPL Replimune > Detailed Quotes

REPL Replimune

Watchlist
28.290
-0.800-2.75%
Close  02/03 16:00 ET
High
29.470
Open
28.490
Turnover
6.63M
Low
26.264
Pre Close
29.090
Volume
232.87K
Market Cap
1.60B
P/E(TTM)
Loss
52wk High
29.523
Shares
56.55M
P/E(Static)
Loss
52wk Low
13.050
Float Cap
1.16B
Bid/Ask %
0.00%
Historical High
54.850
Shs Float
41.05M
Volume Ratio
0.66
Historical Low
8.580
Dividend TTM
--
Div Yield TTM
--
P/B
4.17
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.57%
Amplitude
11.02%
Avg Price
28.486
Lot Size
1
Float Cap
1.16B
Bid/Ask %
0.00%
Historical High
54.850
Shs Float
41.05M
Volume Ratio
0.66
Historical Low
8.580
Dividend TTM
--
P/B
4.17
Dividend LFY
--
Turnover Ratio
0.57%
Amplitude
11.02%
Avg Price
28.486
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Replimune Group, Inc. is a clinical-stage biotechnology company, which engages in the development of oncolytic immunotherapy product candidates through immulytic platform. Its product candidates include RP1, RP2, and RP3. The firm's Oncolytic immunotherapy is a cancer treatment that exploits the ability of certain viruses to selectively replicate in and directly kill tumors, as well as induce a potent, patient-specific, anti-tumor immune response. The company was founded by Philip Astley-Sparke, Colin A. Love and Robert Coffin in March 2015 and is headquartered in Woburn, MA.
CEO: Mr. Philip Astley-Sparke
Market: NASDAQ
Listing Date: 07/20/2018
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist